Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/8265
Title: | Malignant pleural effusion and algorithm management | Authors: | Zarogoulidis K. Zarogoulidis P. Darwiche K. Tsakiridis K. Machairiotis N. Kougioumtzi I. Courcoutsakis N. Terzi E. Zarić, Bojan Huang H. Freitag L. Spyratos D. |
Issue Date: | 1-Jan-2013 | Journal: | Journal of Thoracic Disease | Abstract: | Involvement of the pleura in lung cancer is a common manifestation accompanying with reduced life expectancy. Symptoms relief and improvement of the quality of life are the primary goals of the management of malignant pleural effusion (MPE). Histological confirmation is essential for optimal patient management. Lung cancer patients, with life expectancy more than 3 months, resistant to chemotherapy should be treated with thoracentesis, intercoastal tube drainage and installation of a sclerosant agent or pleurodesis through thoracospopic procedures or placement of an indwelling pleura catheter. Talc pleurodesis (sterile asbestos-free graded, particle size >15 μm), as poudrage or slurry still remains the treatment of choice in patients with MPE resistant to chemotherapy © Pioneer Bioscience Publishing Company. All rights reserved. | URI: | https://open.uns.ac.rs/handle/123456789/8265 | ISSN: | 20721439 | DOI: | 10.3978/j.issn.2072-1439.2013.09.04 |
Appears in Collections: | MDF Publikacije/Publications |
Show full item record
SCOPUSTM
Citations
43
checked on May 10, 2024
Page view(s)
15
Last Week
1
1
Last month
0
0
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.